tradingkey.logo
tradingkey.logo
Pesquisar

Baxter International Inc

BAX
Adicionar à lista de desejos
21.550USD
+0.510+2.42%
Fechamento 06/25, 16:00ETCotações atrasadas em 15 min
11.13BValor de mercado
PerdaP/L TTM

Mais detalhes de Baxter International Inc Empresa

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Informações de Baxter International Inc

Código da empresaBAX
Nome da EmpresaBaxter International Inc
Data de listagemJun 20, 2097
CEOHider (Andrew P)
Número de funcionários38000
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 20
EndereçoOne Baxter Parkway
CidadeDEERFIELD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60015
Telefone12249482000
Sitehttps://www.baxter.com/
Código da empresaBAX
Data de listagemJun 20, 2097
CEOHider (Andrew P)

Executivos da empresa Baxter International Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%

Perguntas frequentes

Quem são os cinco principais acionistas de Baxter International Inc?

Os cinco principais acionistas de Baxter International Inc são: Mr. Andrew P. Hider

Quantas instituições possuem ações da Baxter International Inc (BAX)?

Em 2026Q1, 1767 instituições possuíam ações da Baxter International Inc, com valor de mercado aproximado de 557.84M, representando 108.01% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -45350754.00.

Qual é a maior fonte de receita da Baxter International Inc?

Em 2026Q1, o segmento de negócios Infusion Therapies and Technologies gerou a maior receita para Baxter International Inc, totalizando 4.10B e representando 36.47% da receita total.
KeyAI